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Background/aim: To evaluate the effects of hysterectomy on rat ovaries and the possible protective role of peroxisome proliferatoractivated receptor gamma (PPAR-γ) agonist-rosiglitazone against ovarian reserve decrement.
Materials and methods: Forty-five adult Wistar albino rats were randomly divided into three groups. Hysterectomy was performed (n
= 15) in group 1 [H]; 1 mg/kg/day PPAR-γ agonist/rosiglitazone was used for 50 days after hysterectomy (n = 15) in group 2 [H + R];
a sham operation was performed (n = 15) in group 3 [control, C]. Blood samples were collected for anti-Müllerian hormone (AMH)
evaluation in all groups and simultaneous ovarian Doppler examination was performed in [H] and [H + R] groups before and after (50
days) hysterectomy. All animals were sacrificed to obtain ovaries for histological examination.
Results: AMH levels were found to be significantly decreased at postoperative day 50 in all groups (P < 0.05). Histopathologic analysis
showed that primary, preantral, and antral follicle counts were significantly higher in the [H] group as compared to the [C] and [H +
R] groups (P < 0.05). There was no significant difference between the [C] and [H + R] groups in terms of follicle numbers (P > 0.05).
In the ovarian Doppler blood flow analysis, all parameters were significantly decreased in group [H] (P < 0.05), but not in the [H + R]
group (P > 0.05) on postoperative day 50.
Conclusion: Hysterectomy affects the histopathological structure of rat ovaries and PPAR-γ agonist-rosiglitazone improves the ovarian
Doppler blood flow parameters.
Key words: Hysterectomy, ovarian reserve, rat, Doppler ultrasonography, PPAR gamma, rosiglitazone

1. Introduction
Hysterectomy with ovarian preservation is widely used
for treating a variety of gynecologic conditions such as
symptomatic uterine fibroids, abnormal uterine bleeding,
chronic pelvic pain, etc. in premenopausal women.
Many studies have investigated the possible effects of
hysterectomy on ovarian reserve, ovarian blood flow, and
ovarian histology. Previously, it has been considered that
the ovaries, which are close to the uterus, are affected
by hysterectomy [1–5]. Although it is clear that most
women do not lose ovarian function in the short-term
after hysterectomy, there has long been a suspicion that
these women are at an increased risk of early decrement
in ovarian reserve [6]. Changes in endocrine function may
impact the age-associated decline in physical function

(activities including bathing, dressing, walking, carrying
groceries, etc. according to the physical function subscale
of the Medical Outcomes Study Short-Form 36) [7] and
these changes may be accelerated by hysterectomy. Also,
earlier menopause, in turn, has serious health implications,
including an increased risk of osteoporosis, cardiovascular
disease, and all-cause mortality [8,9]. However, currently,
there are no known treatment options to help prevent
the possible damage that may occur in the ovaries after
hysterectomy.
In vitro/in vivo studies on the use of the peroxisome
proliferator-activated receptor-γ (PPAR-γ) agonist
rosiglitazone as an antidiabetic agent have previously
shown that this agent has antiapoptotic, antihypoxia,
antioxidant, antiinflammatory, neovascularization, and
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antiproliferative effects [10,11]. PPAR-γ receptors provide
folliculogenesis, luteal phase, and ovulation control with
effects on tissue repair [12]. Also, the stimulation of
PPAR-γ receptors provides for the expression of vascular
endothelial growth factor (VEGF), which is responsible for
the formation of new vessels in ovaries [13]. In addition to
these effects on angiogenesis, PPAR-γ causes an increase in
ovarian vascularization by the regulation of endothelin-1
(ET-1) and nitric oxide synthetase (NOS) [13].
In the present study, we used a female rat model that
allowed for ovarian histopathologic assessment, with the
aim of determining the possible effects of hysterectomy on
ovaries. We planned to research the effect of hysterectomy
on the ovaries by examining anti-Müllerian hormone
(AMH) levels and ovarian Doppler blood flow, and by
engaging in histopathologic evaluation. Additionally, we
attempted to investigate the validity of the hypothesis that
PPAR-γ agonist-rosiglitazone can prevent the undesired
effects that may occur in the ovaries after hysterectomy.
2. Materials and methods
2.1. Animals
Forty-five sexually mature, adult, cycling, nonpregnant
Wistar albino rats weighing between 200–250 g (2–3
months old) were used in this study. The rats were housed in
individual metabolic cages for 10 days to acclimatize them
to the study surroundings. Throughout the experiment,
environmental conditions were kept constant: 12 L/12 D
cycle (lights off at 18:00 h), room temperature of 24 ± 1 °C,
and 55% ± 5% relative humidity. The study was approved
by the ethical committee of Ankara Education and
Research Hospital, Ankara, Turkey (33/0001-29.01.2011)
and conducted at the same hospital’s Animal Research
Center (May–August 2011). All investigations complied
with the 1996 National Academy of Science’s Guide for the
Care and Use of Laboratory Animals.
2.2. Study design
Forty-five nonpregnant adult female Wistar albino rats
were used in this study. One week after acclimation,
vaginal smears were performed daily to document the
phase of the estrous cycle. After 2 complete estrous cycles,
the rats in the estrous phase were selected and randomized
into the 3 groups. In group 1 (n = 15), only hysterectomy
was performed [H]; group 2 received rosiglitazone maleate
(Avandia, GlaxoSmithKline, Istanbul, Turkey) for 50 days
after hysterectomy (n = 15) [H + R]; group 3 (n = 15) served
as a control group [C] and underwent a sham operation.
Hysterectomy was performed in the study groups ([H]
and [H + R]) by the same technician (OLT) according
to the technique described by Waynforth and Flecknell
[14,15]. Basal and day-50 AMH levels were measured in
all groups. Doppler examination was performed in the
[H] and [H + R] groups to evaluate the ovarian blood flow
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at basal and postoperative day 50 during the operations.
At postoperative day 50, oophorectomy was performed
on the rats in the estrous phase, confirmed by vaginal
smear. Then, all rats were sacrificed by decapitation. Basal
and postoperative day 50 AMH levels, Doppler analysis,
and ovarian histopathology were compared within and
between the groups (Figure 1).
With this study design, we tried to answer the following
questions as our study outcomes: (1) does hysterectomy
affect the ovaries? and (2) can PPAR-γ agonist-rosiglitazone
therapy counteract the possible effects of hysterectomy on
the ovaries?
2.3. Vaginal smears
Vaginal smears were performed daily to document the
phase of the estrous cycle. Five phases of the estrous cycle
have previously been specified in the literature [14,15].
Homogenization was ensured by operating on the rats in
the estrous phase, which was determined through daily
vaginal smear samples.
2.4. Hysterectomy
A mixture of ketamine, xylazine, and acepromazine
(150:30:5 mg/mL) anesthetics was administered at a dose
of 0.6 mL/kg to rats in the estrous phase. Afterward, while
in the supine position, the abdominal skin of the rats
was shaved prior to surgery and a 10% povidone-iodine
solution was applied to ensure antisepsis. In compliance
with sterility conditions, the abdomen was entered with
a midline incision starting from the top of the urethral
orifice and extending to 3-quarters of the abdomen. Each
uterine horn was pulled out and laid on warm moistened
gauze. The utero-ovarian artery and vein were ligated with
a single suture, both anteriorly and posteriorly, while the
collateral supply to the ovaries and cervix was preserved.
Each uterine horn was cut at its junction with the fallopian
tube and transected at the cervix. Then, the abdomen
was closed by suturing in layers [14,15] (Figure 2a–2d).
Subsequently, the rats were left to recover.
2.5. Rosiglitazone treatment
Rosiglitazone maleate 1 mg/kg per day was given to the [H
+ R] group starting on the day of the surgery and continuing
for 50 days (n = 15) [10]. The drug dose was calculated
according to the rats’ body weight. The rosiglitazone was
given via orogastric tubes after being dissolved in 2 mL
of saline. Every day, each rat was held at the back of the
neck region by an experienced technician. The head was
gently squeezed and fixed with the help of the thumb and
the index finger and an orogastric tube were inserted into
the stomach [11]. We have not seen any side effects with
rosiglitazone.
2.6. Measurement of ovarian Doppler blood flow
After entry into the abdomen of the rats in the [H] and
[H + R] groups, following the visualization of uterine
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Figure 1. Flow chart of the study.

Figure 2a–d. (2a). Entry to the abdomen with a midline incision. (2b). Appearance of uterine horns and
ovaries taken out of the abdomen. (2c). Ovary separated from uterine horn. (2d). Sham suture placed on
fatty tissue so as not to disrupt ovarian blood supply.

horns, the uterine horns were removed and the right and
left ovaries were seen. All measurements were taken by
the same person (SBM) using a portable LOGIQ Book
XP ultrasound (General Electric Healthcare, Solingen,
Germany), with a 6–10 MHz linear probe in a manner that
had a minimal mechanical effect on the ovaries [16]. At
least 3 Power Doppler US (angio mod) images were taken

for each ovary. Images with suitable quality were stored in
the DICOM for Power Doppler. Afterward, the Pixelflux
program (Version 1.0, Chameleon-Software, Leipzig,
Germany) was utilized to obtain dynamic tissue perfusion
measurements on the Power Doppler images. The temporal
variation in intensity (I) red, Vred, average intensity, and
whole intensity values were statistically evaluated [16].
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2.7. Measurement of hormonal parameters
Under the influence of anesthesia, 1–1.5 mL of blood
samples were directly taken intracardially at basal and
postoperative day 50 before decapitation. The collected
blood was centrifuged and the obtained serum was stored
at –20 °C for 55 days for basal samples and 5 days for
postoperative day-50 samples. AMH levels were measured
preoperatively upon enrollment and at postoperative day
50. Serum AMH levels were measured by enzyme-linked
immunosorbent assay (ELISA) using a commercially
available rat AMH ELISA kit (E90228RA, USCN Life
Science Inc., Cloud-Clone Corp., Houston, TX, USA). The
mean sensitivity of the assays was <0.084 ng/mL.
2.8. Histopathologic evaluation of the ovaries
The ovaries of each group were excised at postoperative
day 50 after Doppler analysis and before blood sampling
and decapitation. They were cleared of all adhering fat,
weighed, and processed for histology upon completion
of the studies. Tissues fixed in neutral formaldehyde were
washed, trimmed, dehydrated in a graded series of alcohol,
and cleared in xylene. The tissues were embedded in
paraffin wax and blocks were prepared. Ovarian sections
(6 µm) were obtained from both groups and stained with
hematoxylin and eosin (H&E). Afterward, through the use
of a light microscope, the number of primer, preantral, and
antral follicles and corpora lutea was determined by simple
point counting on serially sectioned left and right ovaries.
All procedures were performed by the same pathologist
(KHM).
2.9. Statistical analyses
Statistical Package for the Social Sciences 20.0 (SPSS Inc.,
Chicago, IL, USA) was used to record and statistically
analyze the data. Normality was tested by the Shapiro–
Wilk test. Nonnormally distributed metric variables were
analyzed by the Kruskal–Wallis test for comparison of
variables among groups. If the difference was significant,
the binary comparisons were done with the Mann–
Whitney U test. The variables in the same group (basal

and postoperative day 50) were analyzed by Wilcoxon’s
signed-rank test. Values were expressed as mean ± standard
deviation (SD) and median (min–max), and statistical
significance was defined as P < 0.05.
3. Results
One rat in the [H] group and 1 rat in the [H + R] group were
lost in the follow-up period. The study was completed with
the remaining 43 rats for all groups.
Baseline serum AMH values were similar for all groups
(P > 0.05). Serum AMH levels significantly decreased in all 3
groups on postoperative day 50 (P < 0.05, P < 0.05, P < 0.01;
P values for the [H], [H + R], and [C] groups, respectively),
but there was no significant difference between the groups
(P > 0.05) (Table 1).
When the ovaries were evaluated histopathologically,
the primary, preantral, and antral follicle numbers in the [H]
group were determined to be higher than those of the [H +
R] and [C] groups (P < 0.001, P < 0.01, P < 0.05; P values
for primary, preantral, and antral follicles, respectively)
(Table 2). However, corpora lutea numbers were found to
be similar between the groups (P > 0.05) (Figures 3a–3d).
When the ovarian Doppler blood flow results were
assessed on postoperative day 50, a significant decrease
was observed in the [H] group for all parameters [intensity
(I)-red average, Vred average, whole intensity, average
intensity], while there was no decrement for all of these
parameters in the [H + R] group (P > 0.05) (Table 3).
4. Discussion
Our primary objective in this study was to investigate the
possible effects of hysterectomy on the ovaries. In our study,
we found that hysterectomy affects the ovaries, and PPAR-γ
agonist-rosiglitazone therapy improves the ovarian Doppler
blood flow parameters in rats.
There are some studies on the measurement of
serum AMH concentrations in women who have had
a hysterectomy with ovarian conservation. The study by

Table 1. Comparison of basal and postoperative 50th-day AMH.
AMH

[H] group (n = 14)
Median (min–max)

[H + R] group (n = 14) [C] group (n = 15)
Median (min–max)
Median (min–max)

Basal AMH

0.72 (0.68–0.79)

0.72 (0.68–7.30)

0.78 (0.65–7.75)

>0.05

50th day AMH

0.62 (0.37–6.30)

0.65 (0.59–0.79)

0.64 (0.58–0.70)

>0.05

P valueb

<0.05*

<0.05*

<0.01*

P valuea

AMH: anti-Müllerian hormone; [H]: hysterectomy; [H + R]: hysterectomy + rosiglitazone; [C]: control; min–
max: minimum–maximum.
a
P value comparing basal and postoperative 50th-day AMH levels among groups.
b
P value comparing basal and postoperative 50th-day AMH levels within groups.
* statistically significant.
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Table 2. Comparison of the histopathologic examination of the ovaries between the groups.
[H] group
(n = 14)
Median (min–max)

[H + R] group
(n = 14)
Median (min–max)

[C] group
(n = 15)
Median (min–max)

Primary follicles

7.5 (3.0–14.0)

2.0 (0–9.0)

3.0 (1.0–5.0)

<0.001*

Preantral follicles

8.0 (3.0–14.0)

4.0 (2.0–11.0)

4.0 (2.0–7.0)

<0.01*

Antral follicles

11.0 (3.0–18.0)

5.5 (3.0–13.0)

7.0 (4.0–12.0)

<0.05*

Corpora lutea

14.0 (8.0–36.0)

11.5 (0–20.0)

12.0 (4.0–28.0)

>0.05

[H] vs. [H + R]
P valueb

[H] vs. [C]
P valuec

[H + R] vs. [C]
P valued

Primary follicles

<0.01*

<0.01*

>0.05

Preantral follicles

<0.01*

<0.01*

>0.05

Antral follicles

<0.05*

<0.05*

>0.05

Corpora lutea

>0.05

>0.05

>0.05

P valuesa

[H]: hysterectomy; [H + R]: hysterectomy + rosiglitazone; [C]: control; min–max: minimum–maximum.
a
P value comparing follicle numbers among groups.
b
P value comparing follicle numbers of [H] vs. [H + R].
c
P value comparing follicle numbers of [H] vs. [C].
d
P value comparing follicle numbers of [H + R] vs. [C].
* statistically significant.

Lee et al. measured serum AMH levels at the baseline,
1st week, 1st month, and 3rd month after hysterectomy;
no significant changes were found in AMH levels [17].
Hehenkamp et al. measured serum FSH and AMH levels in
patients in whom uterine artery ligation and hysterectomy
had been performed. In that study, mean AMH levels were
significantly decreased at the postoperative 6th week and
had subsequently recovered to normal values between the
6th week and the 12th month; they were found to have
remained stable at the 24-month follow-up. As a result,
it was reported that hysterectomy and uterine artery
ligation might affect the ovarian reserve [18]. Wang et
al. measured AMH levels following hysterectomy and
found that serum AMH levels were significantly lower 2
days and 3 months following hysterectomy compared to
the preoperative level [19]. In another study, Atabekoglu
et al. measured preoperative and postoperative 4thmonth serum AMH levels in premenopausal women who
underwent hysterectomy; they found no significant change
[20]. In that study, serum AMH levels decreased at the
4th month for hysterectomy patients and controls, which
is similar to our results [20]. In our study, AMH levels
were significantly decreased in both the hysterectomy and
control groups over time; however, even if the decrease
of AMH levels in the hysterectomy group was accounted
for by the ovaries being affected by hysterectomy, it is
difficult to explain the decrease in the control group with a
similar mechanism. This situation may be explained by the
dissimilarity of AMH metabolism in humans and rodents

and also may be associated with surgical stress, anesthetic
substances, the postoperative process, and potential
changes in the periovarian microenvironment – factors
that may affect the AMH levels of rats in the control group
[21–23]. By contrast, if we had a longer follow-up period,
similar to Hehenkamp’s study [18], AMH levels may have
shown fluctuations and reached their normal values in the
following period. Furthermore, genetic variation in AMH
and AMHR type II (AMHRII) receptor genes were shown
in other studies and could be another explanation for our
results [24].
Morphological evaluation of the ovaries may allow
for a more definite understanding of the effects of
hysterectomy; however, this type of evaluation is not easy
in humans. Sauza et al. reported the potential long-term
effects of hysterectomy on ovarian morphology for the first
time [25]. They performed bilateral ovarian biopsies; then,
1 year after hysterectomy, they performed a laparoscopy
and repeated the ovarian biopsy. They reported that the
ovarian histology showed an impressive reduction in the
follicular reserve, in addition to the thickening of the tunica
albuginea and stromal hyperplasia. It was also reported
that the total number of ovarian follicles in women with
hysterectomy appeared to be significantly lower than the
number of follicles before the operation [25]. Finally,
they concluded that hysterectomy negatively influenced
ovarian function in terms of histology. Ozdamar et al.
evaluated ovarian function in rats following hysterectomy
and found that the numbers of preantral and antral
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A

B

C

D

Figure 3a-d. (3a). Section of an ovary from the [H] group showing numerous primary follicles, and preantral follicle [×200, (H&E)].
(3b). Section of an ovary from the [H + R] group showing preantral and antral follicles and corpus luteum [×100, (H&E)]. (3c). Section
of an ovary from the [H + R] group showing corpus luteum and atretic follicle [×200, (H&E)]. (3d). Section of an ovary from the [C]
group showing primary and antral follicles, and corpus luteum [×200, (H&E)].

follicles decreased, while the numbers of atretic follicles
and corpus luteum increased significantly 6 months after
hysterectomy [26]. In the study conducted by Tapisiz et al.
on rats, when the ovaries were assessed histopathologically
on the 100th day after hysterectomy, a decrease in primary,
preantral, and antral follicle numbers was reported
[15]. The follow-up period in our study is shorter than
those in the other studies, and unlike previous studies,
we found a significant increase in primary, preantral,
and antral follicle numbers in the hysterectomy group
on posthysterectomy day 50. Similarly, Tanaka et al.
demonstrated that hysterectomy increased the number of
ovulations in rats [27]. This condition may be explained by
the stimulation of the hypothalamo-hypophyseal axis and
the start of an autocatalytic cycle as a result of the removal
of the uterus’s inhibitory effect on follicular development
[27]. If the follow-up period had been longer, such as in
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the study of Ozdamar et al. and Tapisiz et al., we may have
observed a decrease in the number of follicles based on
diminishing ovarian reserve [15,26]. Perhaps our study
could show the short-term effects of hysterectomy on
ovarian morphology. Another point to be considered is the
contradiction between the increased number of follicles
and the decreased levels of AMH produced by the follicle
and an indirect evaluation of the follicle pool. Pellatt et
al. examined the production of AMH from follicles and
compared AMH levels between ovulatory and anovulatory
patients with polycystic ovary (PCO) syndrome. At the
end of the study, they found that AMH production per
granulosa cell was 75 times higher in anovulatory PCOs as
compared to normal ovaries and concluded that the raised
levels of AMH could be misleading if used as a marker
of ovarian reserve [28]. In addition, it has been reported
that some biological (race, ethnicity, polymorphisms of
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Table 3. Comparison of basal and postoperative 50th-day Doppler blood flow results between [H] and [H +
R] groups.
Doppler
parameters

Groups

Basal
Mean ± SD
(min–max)

50th Day
Mean ± SD
(min–max)

Difference of 2 days
Median
(min–max)

P valuea

[H]

0.14 ± 0.1
(0.04–0.035)

0.07 ± 0.04
(0.02–0.15)

0.04
(–0.07–0.30)

<0.05*

[H + R]

0.09 ± 0.1
(0.02–0.21)

0.13 ± 0.11
(0.02–0.37)

–0.005
(0.29–0.08)

>0.05

>0.05

<0.05*

<0.05*

[H]

0.49 ± 0.07
(0.41–0.68)

0.41 ± 0.04
(0.33–0.49)

0.07
(–0.02–0.27)

<0.01*

[H + R]

0.47 ± 0.11
(0.38–0.84)

0.45 ± 0.11
(0.34-0.71)

0.03
(–0.23–0.47)

>0.05

>0.05

>0.05

>0.05

[H]

0.14 ± 0.1
(0.04–0.35)

0.07 ± 0.04
(0.02–0.15)

0.04
(–0.07–0.30)

[H + R]

0.09 ± 0.1
(0.02–0.21)

0.13 ± 0.11
(0.02–0.37)

–0.005
(0.29–0.08)

>0.05

<0.05*

<0.05*

[H]

0.07 ± 0.05
(0.02–0.18)

0.04 ± 0.02
(0.01–0.08)

0.02
(–0.04–0.15)

<0.05*

[H + R]

0.05 ± 0.03
(0.01–0.10)

0.07 ± 0.05
(0.01–0.19)

–0.003
(0.15–0.04)

>0.05

>0.05

<0.05*

<0.05*

Ired average

P valueb
Vred
average
P valueb

Whole intensity
P valueb
Average
intensity
P valueb

<0.05*
>0.05

[H]: hysterectomy; [H + R]: hysterectomy + rosiglitazone; [C]: control; min–max: minimum–maximum.
a
P value comparison of basal and postoperative 50th-day Doppler blood flow results within [H] and [H + R].
b
P value comparison of basal and postoperative 50th-day Doppler blood flow results between [H] and [H + R]
groups.
* statistically significant.

AMH and its receptor, systemic illness, etc.), reproductive
(parity, endometriosis, ovarian suppression, etc.), and
environmental/lifestyle (body mass index, current
smoking, low vitamin-D level, etc.) factors may affect
AMH levels [29,30]. Consequently, AMH levels may not
always clearly reflect the ovarian reserve.
The other controversial issues that are thought to cause
a decrease in posthysterectomy ovarian reserve are the
changes occurring in ovarian blood flow [31–34]. Janson et
al. demonstrated an acute reduction of ovarian blood flow
immediately after ligation of the uterine vessels by using
133
Xenon; they assumed that this reduction in blood flow
was responsible for the “steroid drop” after hysterectomy
[34]. Chan et al. found that the ovarian stromal blood flow
was significantly reduced in women with a hysterectomy
and demonstrated that ovarian functions might be

changed [31]. Recently, Lee et al. did not find a significant
difference between the blood flow rate measures of ovarian
arteries before hysterectomy and after a 3-month followup period, which is inconsistent with others [17]. Our
study is the first animal model that examines the effects
of hysterectomy via Doppler ultrasonography on ovarian
blood flow. We found a significant decrease in ovarian
blood flow on postoperative day 50 in the hysterectomy
group. Based on the current results, it may be said that
hysterectomy may disrupt the ovarian blood supply.
It has also been reported that hysterectomy affects the
hemodynamics of ovarian circulation resulting from the
intervention. Through ligation of the uterine artery during
the hysterectomy, the ovarian arteriole pressure increases,
leading to vascular hypertension followed by constriction
of arterioles; this results in a progressive decrease in
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ovarian circulation and consequent ovarian tissue damage
[34,35].
The secondary objective of our study was to investigate
the effects of PPAR-γ agonist rosiglitazone as an antioxidant,
antiinflammatory therapeutic agent on the ovaries after
hysterectomy. PPAR-γ receptor is a ligand-dependent
transcription factor and a member of the nuclear receptor
superfamily. Acting as sensors of hormones, vitamins,
endogenous metabolites, and xenobiotic compounds, the
nuclear receptors control the expression of a very large
number of genes [10–13,36]. Although the literature
contains many publications that indicate the antioxidant
and antiinflammatory effects of PPAR-γ agonists on other
organs [8,9], there is no study about its potential effects on
posthysterectomy ovaries. Our study has the distinction
of being the first animal model performed in connection
with this subject. We found a significant increase in
ovarian blood flow in the rosiglitazone group. Based on
our results and those of other studies [13,36], it may be
speculated that rosiglitazone increases ovarian blood flow
after hysterectomy. Additionally, the amount of follicular
increase in the hysterectomy group was not seen in the
rosiglitazone group. Rosiglitazone may inhibit increased
ovulation as a result of the autocatalytic cycle that may
occur after the hysterectomy, described by Tanaka et al.
[27]. These findings may indicate the protective effect of
rosiglitazone.
Several limitations of this study must be acknowledged.
The first limitation was the shortness of the follow-up
period. However, the estrous cycle of rats was 4–5 days,
and in a 50-day follow-up period, a length of 10–12

cycles, was considered to be analogous to a similar oneyear follow-up period in humans. Multiovulation in rats
may not be generalized to ovulation in humans, which
is the second limitation. It should also be noted that the
study results may contain both type 1 and type 2 errors.
Furthermore, the limited number of rats in each group,
due to ethical principles, was a limitation that may weaken
the statistical significance of these studies. Last but not
least, the difficulty involved in adapting the results of our
study, an animal model, to clinical application in humans
should not be overlooked.
In conclusion, based on the histopathologic changes
and the decrease in AMH levels and ovarian blood flow
findings in our study, it can be said that hysterectomy
affects the ovaries. Additionally, the use of PPAR-γ
agonist-rosiglitazone may reduce the potential negative
effects of hysterectomy on ovaries. Further studies with
larger numbers of human participants are needed to reach
more definite conclusions.
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